ASPIE Right of Review AgreementRight of Review Agreement • November 10th, 2018
This document is the sole document between ASPIE, Inc (hereinafter referred to as “ASPIE”) and any and all Trustees (hereinafter referred to as “the Trustees”) of the Special Needs Trust established for (hereinafter referred to as “the Trust”) or all ABLE account owners established for . It represents a binding contract between ASPE and the Trustees or ABLE account owners for the following:
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. RIGHT OF REVIEW AGREEMENTRight of Review Agreement • August 14th, 2012 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations
This Right of Review Agreement (the “Agreement”) is entered into as of the latest dated signature on the signature page hereto by and between Merrimack Pharmaceuticals, Inc., a Delaware corporation with its principal offices at One Kendall Square, Suite B7201, Cambridge, MA 02139, U.S.A. (the “Company”), and Sanofi, a company incorporated under the laws of France with its principal offices at 54, rue La Boétie, 75008 Paris, France, acting on its behalf and on the behalf of its Affiliates (collectively, “Sanofi”, and together with the Company, the “Parties”).
